Mammographic breast density and cancer risk: The radiological view

Gynecological Endocrinology

Volumn 21, Issue SUPPL. 1, 2005, Pages 6-11

  Yaffe, Martin ^a   Boyd, Norman ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Hormone therapy; Mammogram; Mammographic density; Surrogate marker

Indexed keywords

ESTROGEN; TAMOXIFEN; TUMOR MARKER;

BODY DENSITY; BREAST CANCER; BREAST EXAMINATION; CANCER GRADING; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; DIET; DISEASE CLASSIFICATION; DISEASE MARKER; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; IMAGING SYSTEM; LIFESTYLE; MAMMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VOLUMETRY;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; RADIOGRAPHIC IMAGE ENHANCEMENT; RISK FACTORS; TAMOXIFEN;

EID: 25144431748     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590400030053     Document Type: Conference Paper

References (17)

1. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roetgenol 1976;126:1130-1137.
2. Boyd NF, O'Sullivan B, Campbell JE, Fishell E, Simor I, Cooke G, Germanson T. Mammographic signs as risk factors for breast cancer. Br J Cancer 1982;45:185-193.
3. Brisson J, Merletti F, Sadowsky NL, Twaddle JA, Morrison AS, Cole P. Mammographic features of the breast and breast cancer risk. Am J Epidemiol 1982;115:428-437.
4. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. Am J Roentgenol 1987;148: 1087-1092.
5. Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1989;130:14-24.
6. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN. Mammographic densities and risk of breast cancer. Cancer 1991;67:2833-2838.
7. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Nat Cancer Inst 1995;87:670-675.
8. Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PGA. Nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control 1995;6:431-438.
9. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Nat Cancer Inst 1995;87:1622-1629.
10. van Gils CH, Hendriks JH, Holland R, Karssemeijer N, Otten JD, Straatman H, Verbeek AL. Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev 1999;8:509-515.
11. Lam PB, Vacek PM, Geller BM, Muss HB. The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont. Cancer 2000;89: 369-375.
12. Maskarinec G, Meng L. A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat 2000; 63(2):153-161.
13. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347: 886-894.
14. Lundstrom E, Christow A, Kersemaekers W, Svane G, Azavedo E, Söderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002;186:717-722.
15. Byng JW, Yaffe MJ, Jong RA, Shumak RS, Lockwood GA, Tritchler DL, Boyd NF. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998;18:1587-1598.
16. Pawluczyk O, Augustine BJ, Yaffe MJ, Rico D, Yang J, Mawdsley GE, Boyd NF. A volumetric method for estimation of breast density on digitized screen-film mammograms. Med Phys 2003;30:352-364.
17. Schatzkin A, Gail M. The promise and peril of surrogate end points in cancer research. Nat Rev Cancer 2002;21:19-27.